Learn how KYP supports product approval, product governance, shelf control, and ongoing reassessment of products offered by the dealer.
Know-your-product, or KYP, is the firm’s obligation to understand the products it makes available through its platform and the risks those products create for clients, representatives, and the dealer itself. KYP is not satisfied by obtaining sales materials from an issuer or relying on the fact that a product is popular in the market.
The blueprint tests KYP in applied form. Students should be able to identify whether the firm has done enough due diligence before offering a product and whether the firm has a process for reassessing the product once it is on the shelf.
KYP requires a dealer to understand the product’s structure, features, costs, liquidity, valuation, return expectations, material risks, conflicts, and target market. The level of diligence should reflect the product’s complexity and the type of clients to whom it may be offered.
This means a dealer should not approve a product simply because a supplier says the product is suitable or because a third party has already distributed it elsewhere. The dealer should conduct its own due diligence and be able to explain why the product belongs on its shelf, who it may be suitable for, and what supervisory controls it requires.
KYP is part of product governance, not merely product description. Product governance asks how the dealer controls the lifecycle of a product from approval through distribution, supervision, complaint experience, and possible removal from the shelf.
A strong product-governance framework often includes:
This governance lens is important because the exam often describes a product that was initially approved but later showed warning signs such as client confusion, liquidity stress, concentration risk, or complaint trends.
KYP does not end at the approval meeting. The firm’s ongoing obligation is to reassess products when material information changes or when the dealer’s own experience suggests that the original approval assumptions may no longer hold.
Reassessment triggers may include:
The strongest exam answer recognizes that a dealer should not wait for widespread harm before reconsidering a product.
A dealer approves a structured product after receiving issuer presentations and marketing summaries but does not analyze downside scenarios, liquidity constraints, or the level of investor understanding required. That is weak KYP because the dealer has not truly assessed whether the product can be governed and supervised responsibly.
When judging KYP, ask:
Current CIRO rules distinguish the dealer’s product due diligence obligation from the Approved Person’s know-your-product obligation. The dealer should take reasonable steps to assess product structure, features, risks, costs, and the impact of those costs, approve products before they are made available, and monitor them for significant changes. The Approved Person should then understand approved products well enough to meet suitability obligations.
This means a product can fail in two different ways. The firm may never have approved it properly, or an Approved Person may recommend it without understanding it well enough. The strongest exam answer usually identifies which failure occurred first.
flowchart TD
A[Dealer reviews product structure, risks, and costs] --> B[Dealer approval for product shelf]
B --> C[Approved Person develops product understanding]
C --> D[Product considered for specific client]
D --> E[Suitability determination]
B --> F[Ongoing monitoring for significant changes]
F --> D
The exam logic is sequential: no product approval, no recommendation; no product understanding, no defensible suitability analysis.
A representative begins recommending a new principal-protected note after reading the issuer’s slide deck and attending a sales presentation. The product has not yet completed the dealer’s formal product-approval process, and the representative cannot explain the liquidity limits or cost impact clearly to clients.
What is the strongest analysis?
Correct answer: B.
Explanation: The fact pattern shows both sides of the KYP chain failing. The dealer has not yet completed product due diligence and approval, and the representative lacks a sufficient understanding of the product’s limits and costs. Reputational comfort and issuer training do not replace those obligations.